Target intelligence / Profile preview

Influenza virus proteins M1, M2, NP-A, and NP-B (M1, M2, NP)

Target
M1, M2, NP
Molecular classification
Structural protein, viral matrix protein, Ion channel protein, membrane protein, RNA-binding protein, nucleocapsid protein, Viral protein
01

Overview

Influenza virus matrix protein 1 (M1) forms the virion’s structural scaffold beneath the envelope and regulates assembly, RNA export, and disassembly via pH-sensitive conformational changes. Matrix protein 2 (M2) is an integral membrane ion channel required for viral uncoating and assembly, and is the target of adamantane-class antivirals. Nucleoprotein (NP) of both influenza A and B viruses encapsidates the viral RNA, facilitates nuclear import, and is essential for genome packaging and transcription. These proteins are critical for viral replication and are prominent targets in antiviral drug development and diagnostics.

Other names
Matrix protein 1Matrix protein 2M2 ion channelNucleoproteinnucleocapsid protein
02

Mechanism of action

Drugs targeting M2 inhibit the M2 ion channel, preventing virus uncoating and replication. Inhibitors targeting M1/NP aim to block protein-protein interactions, assembly, or replication, primarily in experimental settings.

03

Biological functions

Virus assemblystructural integrityvRNP (viral ribonucleoprotein) interactionnuclear export of RNAIon channel activityvirus uncoatingassemblymembrane scissionRNA encapsidationprotection from nucleasesnuclear import regulationgenome packaging
04

Disease associations

Influenza A viral infectionsInfluenza B viral infectionsSeasonal epidemicsPandemicsVirulenceDrug resistanceHost adaptation
05

Safety considerations

Rapid resistance development (M2 blockers)Neurological side effects (M2 blockers)Emergence of escape mutants
06

Interacting drugs

Amantadine

1 more in the full profile.

07

Biomarkers

Viral infection biomarkerNP antigen (diagnostic)

Beyond the preview

Go deeper on Influenza virus proteins M1, M2, NP-A, and NP-B (M1, M2, NP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus proteins M1, M2, NP-A, and NP-B (M1, M2, NP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call